PHAT(Phathom Pharmaceuticals, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|
| 营业收入 | $0 | $682.00K | $55.25M | $175.11M |
| 毛利润 | $0 | $515.00K | $47.28M | $152.51M |
| 营业利润 | −$172.44M | −$167.31M | −$277.47M | −$159.99M |
| 净利润 | −$197.72M | −$201.59M | −$334.33M | −$221.25M |
| 经营现金流 | −$146.53M | −$137.58M | −$266.77M | −$166.78M |
| 自由现金流 | −$147.57M | −$139.21M | −$266.90M | −$167.00M |
| 摊薄每股收益 | $-5.05 | $-3.93 | $-5.29 | $-3.03 |